128 related articles for article (PubMed ID: 17459562)
1. Enzyme linked immunosorbent assay (ELISA) as screening method for anti-paternal allo-antibodies in patients with recurrent pregnancy loss (RPL).
Rogenhofer N; Toth B; Kiessig S; Hellstern P; Taborski U; Scholz S; Thaler CJ
Eur J Obstet Gynecol Reprod Biol; 2008 Feb; 136(2):155-9. PubMed ID: 17459562
[TBL] [Abstract][Full Text] [Related]
2. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
3. Comparison of antibody monitoring system with flow cytometric crossmatch test in renal transplant recipients with high panel-reactive antibody.
Hwang HS; Hyoung BJ; Lee SY; Jeon YJ; Yoon HE; Kim JY; Choi BS; Oh EJ; Kim YS; Bang BK; Yang CW
Nephron Clin Pract; 2009; 111(4):c260-4. PubMed ID: 19293595
[TBL] [Abstract][Full Text] [Related]
4. Detection of donor-specific anti-HLA class I and II antibodies using antibody monitoring system.
Yang CW; Oh EJ; Lee SB; Moon IS; Kim DG; Choi BS; Park SC; Choi YJ; Park YJ; Han K
Transplant Proc; 2006 Nov; 38(9):2803-6. PubMed ID: 17112834
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies to plasminogen and tissue plasminogen activator in women with recurrent pregnancy loss.
Bu C; Zhang C; Li Z; Gao L; Xie Z; Cai G
Clin Exp Immunol; 2007 Jul; 149(1):31-9. PubMed ID: 17425656
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies in Argentine women with recurrent pregnancy loss.
Bustos D; Moret A; Tambutti M; Gogorza S; Testa R; Ascione A; Prigoshin N
Am J Reprod Immunol; 2006 Mar; 55(3):201-7. PubMed ID: 16451354
[TBL] [Abstract][Full Text] [Related]
7. The presence of HLA-antibodies in recurrent miscarriage patients is associated with a reduced chance of a live birth.
Nielsen HS; Witvliet MD; Steffensen R; Haasnoot GW; Goulmy E; Christiansen OB; Claas F
J Reprod Immunol; 2010 Dec; 87(1-2):67-73. PubMed ID: 20605049
[TBL] [Abstract][Full Text] [Related]
8. Recurrent pregnancy loss and frequency of eight antiphospholipid antibodies and genetic thrombophilic factors in Czech women.
Subrt I; Ulcova-Gallova Z; Bibkova K; Micanova Z; Hejnalova M; Cerna M; Hradecky L; Novotny Z
Am J Reprod Immunol; 2008 Mar; 59(3):193-200. PubMed ID: 18275512
[TBL] [Abstract][Full Text] [Related]
9. The investigation on the value of repeat and combination test of ACA and anti-beta2-GPI antibody in women with recurrent spontaneous abortion.
Bao SH; Wang XP; Lin QD; Di W; Xu L; Ding CW
Am J Reprod Immunol; 2008 Oct; 60(4):372-8. PubMed ID: 19046144
[TBL] [Abstract][Full Text] [Related]
10. Anti-paternal antibodies by flow cytometry in the management of alloimmunization on recurrent miscarriages.
Matsubayashi H; Maruyama T; Ozawa N; Izumi SI; Sugi T; Yoshikata K; Yoshimura Y; Makino T
Am J Reprod Immunol; 2000 Nov; 44(5):284-8. PubMed ID: 11125790
[TBL] [Abstract][Full Text] [Related]
11. A comparison of flow cytometry and microcytotoxicity for the evaluation of alloimmune therapy in patients with recurrent spontaneous abortions.
Matzner W; Chong P; Xu G; Ching W
Am J Reprod Immunol; 1995 Jan; 33(1):10-3. PubMed ID: 7619223
[TBL] [Abstract][Full Text] [Related]
12. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
13. Relevance of different antibody detection methods for the prediction of antibody-mediated rejection and deceased-donor kidney allograft survival.
Vlad G; Ho EK; Vasilescu ER; Colovai AI; Stokes MB; Markowitz GS; D'Agati VD; Cohen DJ; Ratner LE; Suciu-Foca N
Hum Immunol; 2009 Aug; 70(8):589-94. PubMed ID: 19375470
[TBL] [Abstract][Full Text] [Related]
14. Cytokines in recurrent pregnancy loss.
Daher S; de Arruda Geraldes Denardi K; Blotta MH; Mamoni RL; Reck AP; Camano L; Mattar R
J Reprod Immunol; 2004 Jun; 62(1-2):151-7. PubMed ID: 15288190
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometry crossmatch before kidney transplantation in contemporary practice: target cell utilization, results patterns, and associated long-term graft survival.
Lentine KL; Graff RJ; Xiao H; Modanlou KA; Salvalaggio PR; Brennan DC; Pinsky BW; Burroughs TE; Schnitzler MA
Clin Transpl; 2008; ():253-66. PubMed ID: 19708460
[TBL] [Abstract][Full Text] [Related]
16. Positive B-cell only flow cytometric crossmatch: implications for renal transplantation.
Delgado JC; Eckels DD
Exp Mol Pathol; 2008 Aug; 85(1):59-63. PubMed ID: 18499103
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of a positive flow crossmatch on the outcomes of cadaveric renal transplants.
Ilham MA; Winkler S; Coates E; Rizzello A; Rees TJ; Asderakis A
Transplant Proc; 2008; 40(6):1839-43. PubMed ID: 18675065
[TBL] [Abstract][Full Text] [Related]
18. Improved graft survival in highly sensitized patients undergoing renal transplantation after the introduction of a clinically validated flow cytometry crossmatch.
Limaye S; O'Kelly P; Harmon G; O'Neill D; Dorman AM; Walshe J; Donohoe J; Little D; Conlon PJ; Keogan MT
Transplantation; 2009 Apr; 87(7):1052-6. PubMed ID: 19352127
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxicity and antibody binding by flow cytometry: a single assay to simultaneously assess two parameters.
Saw CL; Bray RA; Gebel HM
Cytometry B Clin Cytom; 2008 Sep; 74(5):287-94. PubMed ID: 18454488
[TBL] [Abstract][Full Text] [Related]
20. Antitrophoblast antibodies are associated with recurrent miscarriages.
Rogenhofer N; Ochsenkühn R; von Schönfeldt V; Assef RB; Thaler CJ
Fertil Steril; 2012 Feb; 97(2):361-6. PubMed ID: 22154370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]